ArticleComputational intelligence and neuroscience2018
A Predictive Model for Guillain-Barré Syndrome Based on Ensemble Methods.
Article in Computational intelligence and neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Patient Outcomes Among Medicare Beneficiaries With Guillain-Barré Syndrome.Journal of the peripheral nervous system : JPNS · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nowadays, Machine Learning methods have proven to be highly effective on the identification of various types of diseases, in the form of predictive models. Guillain-Barré syndrome (GBS) is a potentially fatal autoimmune neurological disorder that has barely been studied with computational techniques and few predictive models have been proposed. In a previous study, single classifiers were successfully used to build a predictive model. We believe that a predictive model is imperative to carry out adequate treatment in patients promptly. We designed three classification experiments: (1) using all four GBS subtypes, (2) One versus All (OVA), and (3) One versus One (OVO). These experiments use a real-world dataset with 129 instances and 16 relevant features. Besides, we compare five state-of-the-art ensemble methods against 15 single classifiers with 30 independent runs. Standard performance measures were used to obtain the best classifier in each experiment. Derived from the experiments, we conclude that Random Forest showed the best results in four GBS subtypes classification, no ensemble method stood out over the rest in OVA classification, and single classifiers outperformed ensemble methods in most cases in OVO classification. This study presents a novel predictive model for classification of four subtypes of Guillain-Barré syndrome. Our model identifies the best method for each classification case. We expect that our model could assist specialized physicians as a support tool and also could serve as a basis to improved models in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.